A paper by a promising nanotechnologist has been retracted for data falsification. Dmitri Lapotko, a Belarusian researcher with a background in laser weaponry, made a name for himself at Rice University in Houston, where he studied the use of nanotechnology to diagnose and treat human diseases. That work earned him significant press coverage, including stories … Continue reading Prominent physicist loses paper over data falsification
The week at Retraction Watch featured a refreshingly honest retraction, and a big win for PubPeer. Here’s what was happening elsewhere:
Nature Communications has issued an expression of concern for a 2014 paper by beleaguered surgeon Paolo Macchiarini, citing concerns over whether the paper accurately reports the experiments that were carried out. According to the notice, Macchiarini, a former rising star in the field of transplant medicine, agrees with the expression of concern. Three of his 22 … Continue reading Macchiarini paper in Nature journal earns expression of concern for data questions
Researchers have retracted and replaced a 2014 paper in JAMA Internal Medicine after realizing a number of errors had affected the findings. The authors note the mistakes do not have a significant impact on the overall proportion of heart patients who participated in cardiac rehab. However, a number of findings were affected, such as the difference in participation … Continue reading Authors retract (and replace) cardiac rehab study in JAMA journal
The week at Retraction Watch featured news of a fine for a doctor who took part in a controversial fake trial, and a likely unprecedented call for retraction by the U.S. FDA commissioner. Here’s what was happening elsewhere:
Yes, argues Roosy Aulakh, an associate professor in the Department of Pediatrics in the Government Medical College and Hospital in Chandigarh, India. In last week’s BMJ, she argues that recent measures to force researchers in India to produce a minimum number of publications to obtain promotions could set the stage for many problems, including fraud. … Continue reading Is it dangerous to set quotas for research output?
The week at Retraction Watch featured a look at whether we have an epidemic of flawed meta-analyses, and the story of a strange case involving climate research and pseudonyms. Here’s what was happening elsewhere:
Paolo Macchiarini — once a world-renowned surgeon for creating tracheas from cadavers and patients’ own stem cells – has been dogged for years by accusations of misconduct. Officials at his institution, Karolinska Institute, initially cleared him of many charges, but that all changed earlier this year, when Swedish Television (SVT) aired a series of documentaries about Macchiarini … Continue reading Meet the filmmakers who cracked open the case against star surgeon Macchiarini
This week at Retraction Watch featured the return of a notorious fraudster, and plagiarism of plagiarism. Here’s what was happening elsewhere:
The week at Retraction Watch featured a shooting by a researcher fired for misconduct, and the creation of fake computer-generated peer reviews. Here’s what was happening elsewhere: